Drug
Circadin
Circadin is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
75%(3 trials)
Phase Distribution
Ph phase_3
1
20%
Ph phase_4
1
20%
Ph phase_2
3
60%
Phase Distribution
0
Early Stage
3
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
3(60.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Other(1)
Detailed Status
Completed4
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 23 (60.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)
Trials by Status
unknown120%
completed480%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs
NCT00816673
completedphase_2
Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor
NCT00940589
completedphase_3
Efficacy and Safety of Circadin® 2 mg in the Treatment of Primary Insomnia Patients
NCT00397189
unknownphase_4
Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic RBD: a Pilot Study
NCT02836743
completedphase_2
A Study of the Efficacy of Prolonged-Release Melatonin Versus Placebo in Diabetic Patients Suffering From Insomnia
NCT00869128
Clinical Trials (5)
Showing 5 of 5 trials
NCT00816673Phase 2
Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs
NCT00940589Phase 2
Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor
NCT00397189Phase 3
Efficacy and Safety of Circadin® 2 mg in the Treatment of Primary Insomnia Patients
NCT02836743Phase 4
Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic RBD: a Pilot Study
NCT00869128Phase 2
A Study of the Efficacy of Prolonged-Release Melatonin Versus Placebo in Diabetic Patients Suffering From Insomnia
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5